Xcenda
Erika Wissinger has a strong background in evidence generation, global value communications, medical communications, and research. With experience in various roles at companies like Xcenda, Evidera, and UBC, as well as a scientific consultant at LA Medica Ltd and Sanofi Pasteur MSD, Erika has showcased their expertise in the field. Erika holds a Ph.D. in Infectious Disease Immunology from the University of Virginia and has also completed a post-graduate certificate in university-level teaching from Imperial College London.
This person is not in any offices
Xcenda
Cencora (formerly AmerisourceBergen/Xcenda), is a strategic consultancy that enables biopharma partners to effectively communicate and deliver their brand's value to key global healthcare stakeholders, driving market access around the world. Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com